Recall of blood components

Lifeblood receives post-donation information with relevance to recipient safety including:

  • the diagnosis of a potential transfusion-transmissible infection (TTI) in a donor via internal or external testing
  • a clinical history suggestive of a potential TTI in a donor 
  • a donor reporting a previously undisclosed risk factor for a TTI that occurred prior to donation, and
  • a donor reporting a previously undisclosed teratogenic medication or vaccination that was administered prior to a donation. 

When fresh blood components presenting a significantly increased risk of harm to the recipient have been transfused, Lifeblood has a duty of care to notify the patient’s clinician.
 
To assist clinicians in evaluating whether recipient notification of potential transmission of an infectious disease is required, Lifeblood has recommendations for the notification of recipients of a recalled blood donation . This resource assists clinicians to decide under what circumstances it would be appropriate to notify the transfused recipient and what actions, if any, to perform for their patient.

Further information

Related topics
Online learning
Need help?